Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DN.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.3.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BW.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.2.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.312NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.13.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.220NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.142NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.523NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.36.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.418NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.389NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.53NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.363NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HV.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.405NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.282NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.228NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17723.5South Korea
B.1.1.174NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17723.5South Korea
AY.88 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KN.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.61NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.37NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XASNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.3.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.86NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.543NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.139NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.31NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.221NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.362NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.265NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.585NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.351NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.383NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.95 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.189NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.545NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used